For the readers interested in the stock health of ChromaDex Corporation (CDXC). It is currently valued at $1.84. When the transactions were called off in the previous session, Stock hit the highs of $1.88, after setting-off with the price of $1.71. Company’s stock value dipped to $1.71 during the trading on the day. When the trading was stopped its value was $1.64.Recently in News on June 15, 2022, ChromaDex to Present at American Society for Nutrition (ASN), International Society of Sports Nutrition (ISSN), and Federation of American Societies for Experimental Biology (FASEB). As a pioneer of nicotinamide adenine dinucleotide (NAD+) and healthy aging research, ChromaDex aims to raise awareness amongst industry leaders. You can read further details here
ChromaDex Corporation had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.0300 on 01/04/22, with the lowest value was $1.5100 for the same time period, recorded on 05/13/22.
ChromaDex Corporation (CDXC) full year performance was -79.53%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ChromaDex Corporation shares are logging -82.93% during the 52-week period from high price, and 21.85% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.51 and $10.78.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 652469 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ChromaDex Corporation (CDXC) recorded performance in the market was -50.80%, having the revenues showcasing -25.51% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 125.76M, as it employees total of 115 workers.
Analysts verdict on ChromaDex Corporation (CDXC)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.2415, with a change in the price was noted -0.92. In a similar fashion, ChromaDex Corporation posted a movement of -33.33% for the period of last 100 days, recording 469,807 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CDXC is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
ChromaDex Corporation (CDXC): Technical Analysis
Raw Stochastic average of ChromaDex Corporation in the period of last 50 days is set at 34.02%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 31.17%. In the last 20 days, the company’s Stochastic %K was 13.85% and its Stochastic %D was recorded 9.40%.
Let’s take a glance in the erstwhile performances of ChromaDex Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -50.80%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -56.40%, alongside a downfall of -79.53% for the period of the last 12 months. The shares increased approximately by 3.95% in the 7-day charts and went down by 4.55% in the period of the last 30 days. Common stock shares were lifted by -25.51% during last recorded quarter.